A global team of researchers at the Max Planck Institute of Biochemistry has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis.
Researchers examined the global prevalence of atopic dermatitis among both pediatric and adult patients and the proportion of these patients who had severe disease.